Greetings from the ACTO chairperson
Akihiro Shimosaka, Ph.D.
Greetings from the Editor-in Chief
Yen Hua Huang, Ph.D.
The ACTO Times Website Performance Report
Vijetha Karen Kitchley, M.Sc.
Before and after “The Stone Age”: Taiwan dual regenerative medicine acts
Thai-Yen Ling, Ph.D.
Welcome New Advisory Board Member
Prof. Kenneth Kaushansky MD, MACP
Welcome New ACTO Vice President Taipei
Dr. Wannhsin Chen
Welcome Message President of 2026 ACTO Annual Meeting
Prof .dr. Amin Soebandrio W. K, PhD, SpMK(K)
Taiwan’s journey from the “Regulations of Special Medical Techniques” framework to the regenerative medicine dual acts: building a full life-cycle system to institutionalize and scale regenerative medicine
Dr. Chung-Liang Shih, M.D., Ph.D.
From Policy Blueprint to Implementation: The Current Status and Future Outlook of Regenerative Medicine in Taiwan
Dr. Yueh-Ping Liu, M.D.
Ushering in a neaw regulatory era for regenerative medicine in Taiwan
Dr. Chih-Kang Chiang, M.D., Ph.D.
Update on regulation of regenerative medicine in Taiwan – The management of the regenerative medicinal products act
Yueh-Tung Tsai, Wen-Hsiu Chiu, Chia-ping Liu, & Chih-Kang Chiang
The new era of regenerative medicine: synergistic development of innovative therapies and the national health insurance system
Lian-Yu Chen, MD., Ph.D.
Indonesia Cell & Gene Therapy (CGT) 2026 Update
Josephine Diony Nanda, M.D., Ph.D.
Regulation of Cell and Gene Therapy (CGT) in Indonesia: Perspective of BPOM
D. Renovaldi, M.Sc.
Beyond Carcinogenesis: Connecting Nicotine Signaling with Cancer Stemness and Metastatic Progression in Triple-Negative Breast Cancer
Yung-Che Kuo, Ph.D. & Yen-Hua Huang, Ph.D.
Artificial Intelligence in Cell Therapy: Advancing Development, Manufacturing, and Clinical Translation
Yu-Xiu Lin, M.SC & Thai-Yen Ling, Ph.D.
Developing Gene Therapy Capacity in Thailand: Clinical, Economic, and Regulatory Perspectives
Kitipong Uaesoontrachoon Ph.D., Parin Rattananon M.D., Usanarat Anurathapan M.D., Suradej Hongeng M.D.
THE ACTO TIMES 